Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Dietz Thomas John Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 17,500 options to buy @ $2.21, valued at $38.7k
04/04/2023 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 175,000 options to buy @ $0.34, valued at $59.5k
03/03/2023 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Granted 40,000 options to buy @ $1.705, valued at $68.2k
02/09/2023 4 Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns: Granted 20,000 shares @ $0
01/25/2023 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Bought 50,000 shares @ $1.4316, valued at $71.6k
09/02/2022 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 30,000 options to buy @ $1.43, valued at $42.9k
03/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2022 4 Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns: Granted 20,000 shares @ $0
02/02/2022 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 60,000 options to buy @ $1.94, valued at $116.4k
04/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/13/2020 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 12,500 options to buy @ $1.69, valued at $21.1k
03/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2020 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Bought 4,000 shares @ $13.94, valued at $55.8k
06/12/2019 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 15,000 options to buy @ $1.39, valued at $20.9k
04/23/2019 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $11.099, valued at $55.5k
04/22/2019 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $11.05, valued at $55.3k
03/25/2019 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $13.41, valued at $268.2k
02/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2019 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 9,375 options to buy @ $2, valued at $18.8k
12/26/2018 4 Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns: Sold 9,330 shares @ $5.01, valued at $46.7k
12/20/2018 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $9.98, valued at $49.9k
12/10/2018 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Bought 5,000 shares @ $11.26, valued at $56.3k
04/20/2018 4 Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.
Txns: Granted 11,250 options to buy @ $7.66, valued at $86.2k
03/16/2018 4 Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.
Txns: Granted 10,000 options to buy @ $9.5, valued at $95k
02/16/2018 4 Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns: Granted 7,500 shares @ $0
Granted 5,000 options to buy @ $0
02/07/2018 4 Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.
Txns: Sold 2,100 shares @ $14.22, valued at $29.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy